As one of the first to go through the new Priority Medicines (PRIME) regulatory initiative in Europe for a New Gene Therapy Treatment for Hemophilia A, we are now looking to build our Commercial team to support the launch Valrox in 2020, lifting the voice of the hemophilia community and making a meaningful impact on patients lives.
The Territory Manager will be focused on pre and post launch preparation and activities, responsible for maximizing sales for the Hemophilia business unit. The ideal candidate will therefore have prior hemophilia and/or rare disease product knowledge, combined with competitive launch experience within a disruptive technology. Patient centricity is critical to our success, so the post holder will be equallyinspired by the aspirations of the hemophilia community and driven to deliver on the ingenuity of gene therapy research.
With a high level of knowledge on the disease state, you will work closely with the treatment centers, HCPs, patient advocacy groups and chapters at local, state or regional level. The position requires a mix of strategic agility, project management, empathy for the community, able to work collaboratively with multiple stakeholders.